EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Procalcitonin in acute and chronic coronary syndromes: Diagnostic biomarker of coronary inflammation

Ozan Sakarya, Burak Toprak, Rıdvan Bora

Biomolecules and Biomedicine · 2025

DOI: 10.17305/bb.2025.12915 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomolecules and Biomedicine, 2025. Verfasst von Ozan Sakarya und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Turgutlu State Hospital, Manisa, Türkiye. Hauptthemen laut MEDLINE: Procalcitonin, Acute Coronary Syndrome, Inflammation, Coronary Artery Disease. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Procalcitonin (PCT) is classically a biomarker of bacterial infection, but its role in cardiovascular inflammation—particularly in coronary artery disease (CAD)—is less well defined. Evidence linking PCT with disease extent and outcomes across acute coronary syndrome (ACS) and chronic coronary syndrome (CCS) remains limited. We compared PCT levels among ACS, CCS, and angiographic controls; examined associations with inflammatory burden and anatomic complexity (SYNTAX score); and evaluated diagnostic performance and short- and intermediate-term prognostic value. In this single-center retrospective study, 477 consecutive adults undergoing diagnostic coronary angiography (December 2019–March 2020) were categorized as ACS (n=190), CCS (n=202), or controls with normal epicardial arteries (n=85). Demographic, laboratory, and angiographic data were collected. PCT was measured within 24 hours of admission. Multivariable logistic regression (using log10-transformed PCT) assessed independent associations with ACS and CCS. Correlations tested relationships with SYNTAX, C-reactive protein (CRP), and troponin-I. Receiver operating characteristic (ROC) analyses quantified discrimination. In ACS, outcomes were compared by PCT ≥0.25 ng/mL. Median PCT was higher in ACS and CCS than in controls (both p

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ProcalcitoninAcute Coronary SyndromeInflammationCoronary Artery DiseaseHumansMaleFemaleBiomarkersMiddle AgedAgedRetrospective StudiesCoronary AngiographyC-Reactive ProteinROC CurvePrognosisChronic Disease

Substanzen

ProcalcitoninBiomarkersC-Reactive Protein

Autor:innen und Institutionen

  • Department of Cardiology, Turgutlu State Hospital, Manisa, Türkiye.
  • Department of Cardiovascular Surgery, Mersin City Education and Research Hospital, Mersin, Türkiye.
  • Department of Cardiology, Tarsus State Hospital, Mersin, Türkiye.

Zitieren

APA

Sakarya, O., Toprak, B., & Bora, R. (2025). Procalcitonin in acute and chronic coronary syndromes: Diagnostic biomarker of coronary inflammation. Biomolecules and Biomedicine. https://doi.org/10.17305/bb.2025.12915

Vancouver

Sakarya O, Toprak B, Bora R. Procalcitonin in acute and chronic coronary syndromes: Diagnostic biomarker of coronary inflammation. Biomolecules and Biomedicine. 2025. doi:10.17305/bb.2025.12915

BibTeX
@article{Sakarya2025,
  author = {Sakarya, Ozan and Toprak, Burak and Bora, Rıdvan},
  title = {Procalcitonin in acute and chronic coronary syndromes: Diagnostic biomarker of coronary inflammation},
  journal = {Biomolecules and Biomedicine},
  year = {2025},
  doi = {10.17305/bb.2025.12915}
}
Kostenlos starten →